-+ 0.00%
-+ 0.00%
-+ 0.00%
MIRA Pharmaceuticals Reports New Findings
Share
Listen to the news

New Findings Highlight MIRA-55's Potent CB2 Activation With More Than 500-Fold Separation From Measured Mu, Delta, and Kappa Opioid Receptor Interactions

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending